Last reviewed · How we verify
Haemophilus b Conjugate Vaccine — Competitive Intelligence Brief
marketed
Biologic
Live · refreshed every 30 min
Target snapshot
Haemophilus b Conjugate Vaccine (Haemophilus b Conjugate Vaccine) — Sanofi Pasteur, a Sanofi Company.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Haemophilus b Conjugate Vaccine TARGET | Haemophilus b Conjugate Vaccine | Sanofi Pasteur, a Sanofi Company | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Haemophilus b Conjugate Vaccine CI watch — RSS
- Haemophilus b Conjugate Vaccine CI watch — Atom
- Haemophilus b Conjugate Vaccine CI watch — JSON
- Haemophilus b Conjugate Vaccine alone — RSS
Cite this brief
Drug Landscape (2026). Haemophilus b Conjugate Vaccine — Competitive Intelligence Brief. https://druglandscape.com/ci/haemophilus-b-conjugate-vaccine. Accessed 2026-05-18.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab